Literature DB >> 29340280

Serum Vitamin D Levels in Treatment-naïve Chronic Hepatitis B Patients.

Ebada Said1, Waleed El Agawy2, Rehab Ahmed2, Mohamed Hassany2, Amal Ahmed3, Hanan Fouad4, Hosam Baiumy1.   

Abstract

BACKGROUND AND OBJECTIVES: According to the demographic health survey conducted in 2015, Egypt had 10% documented prevalence of anti-HBc positive patients aged 1-59 and 1% viremic patients amongst the population in the same age group, with a domination of genotype D. Several studies claimed the possible role of vitamin D deficiency in hepatitis B virus (HBV) replication and disease progression. PATIENTS AND METHODS: Serum vitamin D levels [25(OH D3] were assessed in 96 HBeAg negative non-cirrhotic chronic HBV patients and 25 healthy subjects classified as following: Group I: 48 chronic HBV patients with persistently normal ALT levels and HBV DNA level < 2000 IU/mL for ≥ 6 months; Group II: 48 chronic HBV patients with CHB with persistently elevated ALT and HBV DNA level ≥ 2000 IU/mL for ≥ 6 months; and Group III: 25 apparently healthy subjects with normal liver enzymes and negative hepatitis viral markers were taken as the control group.
RESULTS: Vitamin D was much more deficient in group II than in group I and group III being 11.55 ± 3.97 ng/mL, 15.03 ± 3.45, 27.00 ± 6.76 ng/mL (P < 0.001), respectively, and a strong negative correlation was observed between vitamin D levels and HBV DNA levels (P = 0.043) in groups I and II.
CONCLUSION: The current study showed high HBV DNA replication in patients with vitamin D deficiency suggesting the antimicrobial immunomodulatory role of vitamin D.

Entities:  

Keywords:  Egyptian; hepatitis B virus; vitamin D

Year:  2017        PMID: 29340280      PMCID: PMC5767713          DOI: 10.1515/jtim-2017-0038

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN: 2224-4018


  15 in total

1.  Prevalence of HBV genotypes among Egyptian hepatitis patients.

Authors:  Iman A El Aziz Khaled; Ola M Mahmoud; Abeya F Saleh; Emad E Bioumie
Journal:  Mol Biol Rep       Date:  2010-12-23       Impact factor: 2.316

2.  Vitamin D levels in Egyptian HCV patients (genotype 4) treated with pegylated interferon.

Authors:  A A Mohamed; N A Sabry; M M Abbassi; W A Ibrahim; Z A Ali-Eldin
Journal:  Acta Gastroenterol Belg       Date:  2013-03       Impact factor: 1.316

3.  Vitamin D deficiency among healthy Egyptian females.

Authors:  Raif M Botros; Inas M Sabry; Rania S Abdelbaky; Yara M Eid; Merihan S Nasr; Laila M Hendawy
Journal:  Endocrinol Nutr       Date:  2015-06-10

4.  Prevalence of vitamin D deficiency in chronic liver disease.

Authors:  J Arteh; S Narra; S Nair
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

5.  Vitamin D status in healthy Egyptian adolescent girls.

Authors:  N Amr; A Hamid; M Sheta; H Elsedfy
Journal:  Georgian Med News       Date:  2012-09

6.  Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients.

Authors:  Harald Farnik; Jörg Bojunga; Annemarie Berger; Regina Allwinn; Oliver Waidmann; Bernd Kronenberger; Oliver T Keppler; Stefan Zeuzem; Christoph Sarrazin; Christian M Lange
Journal:  Hepatology       Date:  2013-08-07       Impact factor: 17.425

7.  Vitamin D deficiency and vitamin D therapy in chronic hepatitis C.

Authors:  José M Ladero; María J Torrejón; Pilar Sánchez-Pobre; Avelina Suárez; Francisca Cuenca; Virginia de la Orden; María J Devesa; María Rodrigo; Vicente Estrada; Gustavo López-Alonso; José A Agúndez
Journal:  Ann Hepatol       Date:  2013 Mar-Apr       Impact factor: 2.400

Review 8.  Vitamin D deficiency and insufficiency in Africa and the Middle East, despite year-round sunny days.

Authors:  R J Green; G Samy; M S Miqdady; M El-Hodhod; O O Akinyinka; G Saleh; J Haddad; S A Alsaedi; A Y Mersal; A Edris; M Salah
Journal:  S Afr Med J       Date:  2015-07

9.  Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?

Authors:  James E Nelson; Christian L Roth; Laura A Wilson; Katherine P Yates; Bradley Aouizerat; Vicki Morgan-Stevenson; Elizabeth Whalen; Andrew Hoofnagle; Michael Mason; Vivian Gersuk; Matthew M Yeh; Kris V Kowdley
Journal:  Am J Gastroenterol       Date:  2016-03-22       Impact factor: 10.864

10.  Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.

Authors:  Veronika Fedirko; Talita Duarte-Salles; Christina Bamia; Antonia Trichopoulou; Krasimira Aleksandrova; Dimitrios Trichopoulos; Elisabeth Trepo; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Marina Kvaskoff; Tilman Kühn; Annie Lukanova; Heiner Boeing; Brian Buijsse; Eleni Klinaki; Chrysanthi Tsimakidi; Alessio Naccarati; Giovanna Tagliabue; Salvatore Panico; Rosario Tumino; Domenico Palli; H Bas Bueno-de-Mesquita; Peter D Siersema; Petra H Peters; Eiliv Lund; Magritt Brustad; Karina Standahl Olsen; Elisabete Weiderpass; Raul Zamora-Ros; María-José Sánchez; Eva Ardanaz; Pilar Amiano; Carmen Navarro; J Ramón Quirós; Mårten Werner; Malin Sund; Björn Lindkvist; Johan Malm; Ruth C Travis; Kay-Tee Khaw; Magdalena Stepien; Augustin Scalbert; Isabelle Romieu; Pagona Lagiou; Elio Riboli; Mazda Jenab
Journal:  Hepatology       Date:  2014-08-28       Impact factor: 17.425

View more
  1 in total

1.  The rationale for a multi-step therapeutic approach based on antivirals, drugs and nutrients with immunomodulatory activity in patients with coronavirus-SARS2-induced disease of different severities.

Authors:  Sirio Fiorino; Maddalena Zippi; Claudio Gallo; Debora Sifo; Sergio Sabbatani; Roberto Manfredi; Edoardo Rasciti; Leonardo Rasciti; Enrico Giampieri; Ivan Corazza; Paolo Leandri; Dario de Biase
Journal:  Br J Nutr       Date:  2020-07-24       Impact factor: 3.718

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.